We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.96 (15.947%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.50
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Feb 2007 15:16

Synairgen plc23 February 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of Synairgen plcexisting shares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights ( ) An acquisition or disposal of financial instruments which may result in the ( )acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights ( ) Other (please specify): Confirmation of our Xholding___________________________________ 3. Full name of person(s) subject to the AMVESCAP plcnotification obligation: 4. Full name of shareholder(s) (if differentfrom 3.): 5. Date of the transaction (and date on whichthe threshold is crossed or reached ifdifferent): 6. Date on which issuer notified: 23 February 2007 7. Threshold(s) that is/are crossed or reached: 5%, 6% 8. Notified details: - A: Voting rights attached to sharesClass/type of Situation previous to the Resulting situation after the triggering transactionshares Triggering transaction if possible Number of Number of Number of Number of voting % of voting rightsusing the ISIN Shares Voting Rights shares rightsCODE Direct Direct Indirect Direct Indirect Ordinary 1p 1,314,211 1,314,211 1,314,211 1,314,211 6.05%Shares(GB00B0381Z20) B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ converted. - Total (A+B)Number of voting rights % of voting rights1,314,211 6.05% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable: Chase Nominees - 743,836 Vidacos Nominees - 570,375 Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold votingrights: 13. Additional information: 14. Contact name: John Ward 15. Contact telephone number: 02380 512800 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Nov 20237:00 amRNSGrant of Options
11th Oct 20237:00 amRNSAppointment of New Chief Financial Officer
3rd Oct 20237:00 amRNSAppointment of Chief Medical Officer
21st Sep 20237:00 amRNSInterim Results
29th Jun 20236:02 pmRNSResult of AGM
29th Jun 202310:00 amRNSAnnual General Meeting Presentation
22nd Jun 20237:00 amRNSGrant of Options
23rd May 20237:00 amRNSPosting of Annual Report and Notice of AGM
27th Apr 20237:00 amRNS2022 Full Year Results
17th Apr 20237:00 amRNSNotice of Full Year results
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20234:40 pmRNSSecond Price Monitoring Extn
3rd Feb 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20234:35 pmRNSPrice Monitoring Extension
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Dec 202211:30 amRNSSPRINTER Trial Results Published
14th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSBoard Changes
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20224:40 pmRNSSecond Price Monitoring Extn
3rd Nov 20224:35 pmRNSPrice Monitoring Extension
20th Oct 20224:35 pmRNSPrice Monitoring Extension
6th Oct 20221:35 pmRNSHolding(s) in Company
4th Oct 20227:02 amRNSData from the US NIH-led ACTIV-2 Phase 2 trial
29th Sep 20227:01 amRNSBoard Changes
29th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSSPRINTER Long COVID data presented at IDWeek
15th Sep 20227:00 amRNSNotice of Interim Results
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSPositive Findings from SG015 Tri-al Analysis
5th Sep 20227:00 amRNSCompany Announce Collaboration on UNIVERSAL Trial
6th Jul 20227:00 amRNSGrant of Options
30th Jun 20221:45 pmRNSResult of AGM
23rd Jun 20224:40 pmRNSSecond Price Monitoring Extn
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
15th Jun 20222:30 pmRNSHolding(s) in Company
9th Jun 20223:00 pmRNSExercise of Options and Total Voting Rights
6th Jun 20224:25 pmRNSPosting of Annual Report & Notice of AGM
25th May 20227:00 amRNSFull Year Results
18th May 20224:36 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSSynairgen presents at ATS 2022
25th Apr 20227:00 amRNSPresentation at ECCMID
19th Apr 20224:40 pmRNSSecond Price Monitoring Extn
19th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20222:10 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSSynairgen to present at ATS 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.